A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
Clinical trial NCT00771043 · WITHDRAWN
Trial details
- NCT number
- NCT00771043
- Sponsor
- Biogen
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.